2016
DOI: 10.1007/s00784-016-2031-9
|View full text |Cite
|
Sign up to set email alerts
|

Opiorphin in burning mouth syndrome patients: a case-control study

Abstract: Opiorphin may be a measurable biomarker for chronic pain, which could help in objectifying otherwise exclusively a subjective experience. Increased opiorphin could serve as a universal objective indicator of painful conditions. Since opiorphin may also reflect emotional and socio-relational imbalances occurring with BMS, it could as well represent a biomarker for BMS. Knowledge on opiorphin's involvement in pain pathways could contribute to developing new clinical diagnostic methods for BMS.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
46
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(52 citation statements)
references
References 34 publications
0
46
0
Order By: Relevance
“…Although declarative in nature, to our knowledge, no study to date has compared opiorphin to healthy children with and without self-declared past 10 Mediators of Inflammation distressing events. OPI has been described as a potent endogenous antinociceptive [67] and stress-related peptide [28,30,67] in adults. Similarly, in female adolescents affected by eating disorders, salivary changes in OPI and sIgA were observed, suggesting a possible use of OPI as a neurobiological salivary biomarker of malnutrition [27].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Although declarative in nature, to our knowledge, no study to date has compared opiorphin to healthy children with and without self-declared past 10 Mediators of Inflammation distressing events. OPI has been described as a potent endogenous antinociceptive [67] and stress-related peptide [28,30,67] in adults. Similarly, in female adolescents affected by eating disorders, salivary changes in OPI and sIgA were observed, suggesting a possible use of OPI as a neurobiological salivary biomarker of malnutrition [27].…”
Section: Discussionmentioning
confidence: 99%
“…Opiorphin (OPI) is a polypeptide recently discovered in human saliva, increasing the bioavailability of enkephalins acting on μand δ-opioid receptors in the central nervous system (CNS), therefore displaying analgesic and antidepressant properties [16][17][18][19][20][21][22][23][24][25]. Salivary OPI secretion depends on ovarian cycles and hormonal status [18], which are known to affect the trophism of oral tissues [26][27][28][29]. OPI also plays a role in oral pain [26,28,30] and mental stress [27].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Saliva and serum were sampled before any surgical procedure between 7 and 9 a.m. in a dark room (< 3 lux). All samples were obtained in the same conditions and by using the specially designed saliva collecting apparatus [26]. Unstimulated and stimulated saliva samples were obtained from every subject.…”
Section: Saliva and Serum Samplingmentioning
confidence: 99%
“…However, the direct role of opiorphin in BMS is not supported although its blood levels may indicate a systemic deregulation in these patients. [18][19][20]…”
Section: And Therapeutic Implicationmentioning
confidence: 99%